You can buy or sell Acasti Pharma and other stocks, options, and ETFs commission-free!
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. The listed name for ACST is Acasti Pharma, Inc. Class A Common Stock.
52 Week High
52 Week Low
— per share
Expected Jun 29, Pre-Market